Acumen Pharmaceuticals (ABOS) Institutional Ownership → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free ABOS Stock Alerts $3.80 +0.15 (+4.11%) (As of 10:53 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Acumen Pharmaceuticals (NASDAQ:ABOS)CurrentInstitutional OwnershipPercentage71.01%Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$54.81MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.08M Get ABOS Insider Trade Alerts Want to know when executives and insiders are buying or selling Acumen Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ABOS Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Acumen Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Ikarian Capital LLC266,435$1.08M0.1%-15.5%0.443% 5/15/2024 Price T Rowe Associates Inc. MD1,098,276$4.45M0.0%N/A1.828% 5/10/2024 Vanguard Group Inc.1,665,058$6.74M0.0%-9.5%2.771% 5/7/2024Susquehanna Fundamental Investments LLC62,518$253K0.0%N/A0.104% 5/7/2024 SG Americas Securities LLC12,856$52K0.0%N/A0.021% 2/23/2024 Chicago Partners Investment Group LLC18,315$70K0.0%+34.9%0.032% Get the Latest News and Ratings for ABOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024 Parkman Healthcare Partners LLC603,497$2.32M0.3%+20.7%1.042% 2/9/2024 Franklin Resources Inc.3,358,809$12.90M0.0%+18.3%5.800% 2/7/2024 Jump Financial LLC103,000$396K0.0%+203.8%0.178% 12/7/2023 Hudson Bay Capital Management LP525,000$2.18M0.0%+32.9%0.907% 12/6/2023 Citigroup Inc.38,498$160K0.0%+5,423.4%0.066% 11/15/2023 RA Capital Management L.P.14,932,063$61.97M1.2%+52.8%25.803% 11/15/2023 Rock Springs Capital Management LP2,812,579$11.67M0.3%N/A4.860% 11/15/2023 Laurion Capital Management LP1,895,023$7.86M0.0%+57.1%3.275% 11/14/2023 Schonfeld Strategic Advisors LLC645,112$2.68M0.0%N/A1.115% 11/14/2023 Knollwood Investment Advisory LLC1,628,510$6.76M3.2%N/A2.814% 11/13/2023 DekaBank Deutsche Girozentrale40,000$167K0.0%N/A0.069% 11/8/2023Pathstone Family Office LLC478,790$1.99M0.0%+2.5%0.827% 11/7/2023 Jump Financial LLC33,900$141K0.0%N/A0.059% 11/3/2023 Intrepid Financial Planning Group LLC30,150$125K0.1%+49.6%0.052% 10/26/2023 Chicago Partners Investment Group LLC13,579$56K0.0%N/A0.023% 9/21/2023Baystate Wealth Management LLC18,020$87K0.0%N/A0.031% 8/14/2023 Deep Track Capital LP3,916,361$18.84M0.9%-0.9%6.768% 8/14/2023 Prelude Capital Management LLC31,100$150K0.0%N/A0.076% 8/2/2023 Catalyst Financial Partners LLC89,699$431K0.2%N/A0.219% 8/2/2023Baystate Wealth Management LLC18,020$87K0.0%N/A0.044% 7/27/2023 Pinnacle Associates Ltd.18,020$87K0.0%N/A0.044% 5/16/2023 Great Point Partners LLC1,051,267$4.27M0.8%-5.8%2.563% 5/15/2023 Commodore Capital LP400,000$1.62M0.2%-19.7%0.975% 5/15/2023 Guardian Point Capital LP130,000$528K0.4%-56.7%0.317% 5/3/2023 Jump Financial LLC10,183$41K0.0%-52.1%0.025% 5/2/2023 Intrepid Financial Planning Group LLC30,150$122K0.1%+201.5%0.073% 4/26/2023 Chicago Partners Investment Group LLC12,332$47K0.0%-34.0%0.030% 2/14/2023 Moore Capital Management LP27,578$149K0.0%-93.5%0.068% 2/14/2023 683 Capital Management LLC31,246$169K0.0%N/A0.077% 2/14/2023 Driehaus Capital Management LLC563,864$3.05M0.0%-1.3%1.392% 2/13/2023Pathstone Family Office LLC530,330$2.86M0.0%+109.4%1.309% 2/10/2023Cheyne Capital Management UK LLP55,829$301K0.5%N/A0.138% 2/9/2023 Chicago Partners Investment Group LLC18,679$109K0.0%+68.5%0.046% 2/7/2023 WMS Partners LLC98,301$531K0.1%-45.4%0.243% What President Biden's new law means for investors (Ad)What's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately.2/2/2023 Intrepid Financial Planning Group LLC10,000$54K0.0%N/A0.025% 2/1/2023 Bank of Montreal Can58,400$326K0.0%N/A0.144% 11/15/2022Pathstone Family Office LLC253,270$2.54M0.0%N/A0.625% 11/15/2022 Perceptive Advisors LLC400,000$4.01M0.1%-21.3%0.988% 11/15/2022 Endurant Capital Management LP55,328$555K0.2%N/A0.137% 11/15/2022 Commodore Capital LP1,100,000$11.03M1.8%N/A2.716% 11/14/2022 Point72 Asset Management L.P.40,936$411K0.0%N/A0.101% 11/14/2022 Boothbay Fund Management LLC62,580$628K0.0%+391.7%0.155% 11/14/2022 Moore Capital Management LP422,902$4.24M0.1%+18.0%1.044% 11/3/2022 Barclays PLC34,161$342K0.0%+408.0%0.084% 10/28/2022 Silverarc Capital Management LLC420,000$4.21M1.4%N/A1.037% 8/16/2022 Woodline Partners LP426,170$2.00M0.0%-15.0%1.052% 8/15/2022 Laurion Capital Management LP1,206,548$5.67M0.1%+83.7%2.979% 8/13/2022Virtu Financial LLC26,204$123K0.0%N/A0.065% 5/17/2022 Great Point Partners LLC928,282$3.63M0.9%N/A2.292% 5/16/2022 Deep Track Capital LP2,599,098$10.16M0.7%+34.5%6.418% 5/13/2022 Fiduciary Group LLC10,000$31K0.0%N/A0.025% 5/10/2022 WMS Partners LLC181,068$708K0.1%N/A0.447% 5/6/2022 Los Angeles Capital Management LLC56,592$221K0.0%N/A0.140% 5/5/2022 New York State Common Retirement Fund23,981$94K0.0%+337.5%0.059% 4/21/2022 Strs Ohio41,300$161K0.0%+24.0%0.102% 2/19/2022 Woodline Partners LP480,681$3.25M0.0%+2.5%1.188% 2/14/2022 Deep Track Capital LP1,933,040$13.07M0.9%N/A4.776% 2/8/2022 Northern Trust Corp94,984$642K0.0%+8.7%0.235% 2/2/2022 New York State Common Retirement Fund5,481$37K0.0%N/A0.014% 1/24/2022 Strs Ohio33,300$225K0.0%+1,413.6%0.082% 11/16/2021 Janus Henderson Group PLC860,181$12.77M0.0%N/A2.126% 11/16/2021 Laurion Capital Management LP656,848$9.76M0.0%N/A1.623% 11/16/2021 Moore Capital Management LP369,583$5.49M0.1%N/A0.913% 11/16/2021 BVF Inc. IL289,663$4.30M0.2%N/A0.716% 11/15/2021 Pura Vida Investments LLC75,000$1.12M0.0%N/A0.185% 11/15/2021 Rock Springs Capital Management LP1,579,191$23.47M0.5%N/A3.902% 11/15/2021 Marshall Wace LLP156,250$2.32M0.0%N/A0.386% 11/15/2021 RA Capital Management L.P.9,770,773$145.19M2.0%N/A24.144% 11/15/2021 Franklin Resources Inc.937,500$13.93M0.0%N/A2.317% 11/12/2021 Geode Capital Management LLC107,806$1.60M0.0%N/A0.266% 11/10/2021 Goldman Sachs Group Inc.63,635$946K0.0%N/A0.157% 11/9/2021 BlackRock Inc.2,868,791$42.63M0.0%N/A7.089% 11/4/2021 Sands Capital Ventures LLC3,417,075$50.78M7.7%N/A8.444% 11/4/2021 Deutsche Bank AG5,518$82K0.0%N/A0.014% (Data available from 1/1/2016 forward) ABOS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABOS shares? During the previous two years, 41 institutional investors and hedge funds held shares of Acumen Pharmaceuticals. The most heavily invested institutionals were RA Capital Management L.P. ($61.97M), Deep Track Capital LP ($18.84M), Franklin Resources Inc. ($12.90M), Rock Springs Capital Management LP ($11.67M), Laurion Capital Management LP ($7.86M), Knollwood Investment Advisory LLC ($6.76M), and Vanguard Group Inc. ($6.74M).Learn more on ABOS's institutional investors. What percentage of Acumen Pharmaceuticals stock is owned by institutional investors? 71.01% of Acumen Pharmaceuticals stock is owned by institutional investors. Learn more on ABOS's institutional investor holdings. Which institutional investors have been buying Acumen Pharmaceuticals stock? Of the 32 institutional investors that purchased Acumen Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($5.16M), Rock Springs Capital Management LP ($2.81M), Knollwood Investment Advisory LLC ($1.63M), Laurion Capital Management LP ($1.24M), Commodore Capital LP ($1.10M), Price T Rowe Associates Inc. MD ($1.10M), and Schonfeld Strategic Advisors LLC ($645.11K). How much institutional buying is happening at Acumen Pharmaceuticals? Institutional investors have bought a total of 16,306,475 shares in the last 24 months. This purchase volume represents approximately $80.14M in transactions. Which Acumen Pharmaceuticals major shareholders have been selling company stock? Of the 13 institutional investors that sold Acumen Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Moore Capital Management LP ($395.32K), Vanguard Group Inc. ($174.49K), Guardian Point Capital LP ($170K), Perceptive Advisors LLC ($108.53K), Commodore Capital LP ($98.32K), WMS Partners LLC ($81.77K), and Woodline Partners LP ($75.07K). How much institutional selling is happening at Acumen Pharmaceuticals? Institutional investors have sold a total of 1,278,244 shares in the last 24 months. This volume of shares sold represents approximately $6.56M in transactions. Related Companies: CMPX Institutional Ownership ZURA Institutional Ownership AGEN Institutional Ownership OVID Institutional Ownership IPHA Institutional Ownership OPT Institutional Ownership INMB Institutional Ownership CHRS Institutional Ownership IPSC Institutional Ownership KOD Institutional Ownership This page (NASDAQ:ABOS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acumen Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.